| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | ursodeoxycholic acid (Cholurso®) |
| Formulation | 250 mg and 500 mg film-coated tablet |
| Reference number | 3439 |
| Indication | Treatment of primary biliary cirrhosis (PBC) in adult patients without decompensated cirrhosis. Dissolution of radiolucent cholesterol gallstones not larger than 15 mm in diameter in patients with a functioning gallbladder and for whom surgical treatment is not indicated |
| Company | HFA Healthcare Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 07/03/2017 |